Schizophrenia Bulletin Advance Access originally published online on February 16, 2005
Schizophrenia Bulletin 2005 31(1):139-153; doi:10.1093/schbul/sbi005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Construct Validity of the Animal Latent Inhibition Model of Selective Attention Deficits in Schizophrenia
Professor, Department of Psychology, Tel Aviv University, Tel Aviv, Israel
Send reprint requests to Dr. R. E. Lubow, Department of Psychology, Tel Aviv University, Ramat Aviv 69978, Israel; e-mail: lubow{at}freud.tau.ac.il.
Latent inhibition (LI) is demonstrated when a previously unattended/inconsequential stimulus is less effective in a new learning situation than a novel stimulus. In rats and humans, LI is reduced by dopamine agonists and increased by dopamine antagonists. In addition, LI is attenuated in actively psychotic schizophrenia patients, thus conferring strong predictive validity to the animal LI preparation for schizophrenia. However, the validity of the attentional construct in the LI model of schizophrenia dysfunction depends on confirming two assumptions: that animal and human LI share a common process, and that the process is related to selective attention. Evidence to support both assumptions is presented, followed by a description of a conditioned attention theory that emphasizes the role of initial levels of attention elicited by repeated relevant and irrelevant stimuli, and the differences between these levels in schizophrenia and normal groups.
Keywords: Schizophrenia / schizotypal / dopamine / latent inhibition / attention / construct validity / predictive validity / animal model
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
U. Meyer, J. Feldon, and B. K. Yee A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia Schizophr Bull, September 1, 2009; 35(5): 959 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Meyer, E. Spoerri, B. K. Yee, M. J. Schwarz, and J. Feldon Evaluating Early Preventive Antipsychotic and Antidepressant Drug Treatment in an Infection-Based Neurodevelopmental Mouse Model of Schizophrenia Schizophr Bull, October 8, 2008; (2008) sbn131v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Silverstein Measuring Specific, Rather than Generalized, Cognitive Deficits and Maximizing Between-Group Effect Size in Studies of Cognition and Cognitive Change Schizophr Bull, July 1, 2008; 34(4): 645 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J Hagan and D. N C Jones Predicting Drug Efficacy for Cognitive Deficits in Schizophrenia Schizophr Bull, October 1, 2005; 31(4): 830 - 853. [Abstract] [Full Text] [PDF] |
||||
